Filing Details

Accession Number:
0001213900-17-006527
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-06-15 16:51:34
Reporting Period:
2017-06-15
Filing Date:
2017-06-15
Accepted Time:
2017-06-15 16:51:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1388320 Actinium Pharmaceuticals Inc. ATNM Pharmaceutical Preparations (2834) 880378336
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1615840 Steve O'loughlin C/O Actinium Pharmaceuticals, Inc
275 Madison Avenue, 7Th Floor
New York NY 10016
Principal Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-06-15 3,500 $1.17 3,500 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct